Showing results (91-100 of 744) with videos related to
Sort By:
Pageof 75
F1000 Biology Reports|October 16, 2010
PARP inhibitors in BRCA1/BRCA2 germline mutation carriers with ovarian and breast cancerChristina M Annunziata, Susan E BatesJournal of Behavioral Medicine|November 8, 2015
Hey Mr. Sandman: dyadic effects of anxiety, depressive symptoms and sleep among married couplesTracey A Revenson, Amanda M Marín-Chollom, Andrew G Rundle, et al.Cancer|December 16, 2011
Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973-2008Reem Z Sharaiha, Ben Lebwohl, Laura Reimers, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 10, 2008
Cigarette smoking and risk of lung metastasis from esophageal cancerJulian A Abrams, Paul C Lee, Jeffrey L Port, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysisDawn Hershman, Vijaya Sundararajan, Judith S Jacobson, et al.Cancer Detection and Prevention|April 20, 2006
Breast biopsy and race/ethnicity among women without breast cancerJudith S Jacobson, Victor R Grann, Dawn Hershman, et al.Annals of Internal Medicine|March 5, 2002
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancerVijaya Sundararajan, Nandita Mitra, Judith S Jacobson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2002
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysisVictor R Grann, Judith S Jacobson, Dustin Thomason, et al.The American Journal of Medicine|August 26, 2003
Risk of malignancy in patients with celiac diseasePeter H R Green, Aaron T Fleischauer, Govind Bhagat, et al.Gynecologic Oncology|January 31, 2004
Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based studyDawn Hershman, Aaron T Fleischauer, Judith S Jacobson, et al.Pageof 75